Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
מצבים רפואיים
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Mary Greeley Medical Center, Ames, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Ames, Ames, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Boone, Boone, Iowa, United States
McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)McFarland Clinic - Jefferson, Jefferson, Iowa, United States
McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States
Contact: Principal Investigator (Joseph J. Merchant)Tufts Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Site Public Contact) · ContactUsCancerCenter@TuftsMedicalCenter.org · 617-636-5000Contact: Principal Investigator (Raymond L. Comenzo)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Clifton C. Mo)Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States
Contact: Principal Investigator (Donald J. Jurgens)Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Commack, Commack, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Westchester, Harrison, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Saad Z. Usmani)OhioHealth O'Bleness Hospital, Athens, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Riverside Methodist Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Grant Medical Center, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Doctors Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Grady Memorial Hospital, Delaware, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Columbus Oncology and Hematology Associates, Dublin, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)Dublin Methodist Hospital, Dublin, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Mansfield Hospital, Mansfield, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Marion General Hospital, Marion, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Pickerington Methodist Hospital, Pickerington, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)OhioHealth Westerville Medical Campus/Westerville Cancer Center, Westerville, Ohio, United States
Contact: Principal Investigator (Yvonne A. Efebera)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Muhammad Salman Faisal)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Muhamed Baljevic)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Douglas W. Sborov)Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Ravi Kishore Narra)ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Sheboygan Physicians Group, Sheboygan, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581Contact: Principal Investigator (Adedayo A. Onitilo)Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States
Contact: Principal Investigator (Anthony J. Jaslowski)ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States
Contact: Principal Investigator (Timothy R. Wassenaar)Marshfield Medical Center - Weston, Weston, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581Contact: Principal Investigator (Adedayo A. Onitilo)